BMY vs. SCHD
Compare and contrast key facts about Bristol-Myers Squibb Company (BMY) and Schwab U.S. Dividend Equity ETF (SCHD).
SCHD is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Dividend 100 Index. It was launched on Oct 20, 2011.
Performance
BMY vs. SCHD - Performance Comparison
Loading graphics...
BMY vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 15.79% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
SCHD Schwab U.S. Dividend Equity ETF | 12.17% | 4.34% | 11.66% | 4.54% | -3.26% | 29.87% | 15.03% | 27.29% | -5.56% | 20.85% |
Returns By Period
In the year-to-date period, BMY achieves a 15.79% return, which is significantly higher than SCHD's 12.17% return. Over the past 10 years, BMY has underperformed SCHD with an annualized return of 2.90%, while SCHD has yielded a comparatively higher 12.25% annualized return.
BMY
- 1D
- 1.78%
- 1M
- -0.98%
- YTD
- 15.79%
- 6M
- 33.50%
- 1Y
- 8.90%
- 3Y*
- 0.70%
- 5Y*
- 3.49%
- 10Y*
- 2.90%
SCHD
- 1D
- -0.55%
- 1M
- -3.43%
- YTD
- 12.17%
- 6M
- 12.91%
- 1Y
- 13.70%
- 3Y*
- 11.84%
- 5Y*
- 8.32%
- 10Y*
- 12.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMY vs. SCHD — Risk / Return Rank
BMY
SCHD
BMY vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMY | SCHD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.31 | 0.88 | -0.56 |
Sortino ratioReturn per unit of downside risk | 0.64 | 1.32 | -0.68 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.19 | -0.11 |
Calmar ratioReturn relative to maximum drawdown | 0.25 | 1.05 | -0.80 |
Martin ratioReturn relative to average drawdown | 0.39 | 3.55 | -3.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BMY | SCHD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.31 | 0.88 | -0.56 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.58 | -0.43 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | 0.74 | -0.62 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.84 | -0.49 |
Correlation
The correlation between BMY and SCHD is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BMY vs. SCHD - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.03%, more than SCHD's 3.46% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.03% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
SCHD Schwab U.S. Dividend Equity ETF | 3.46% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Drawdowns
BMY vs. SCHD - Drawdown Comparison
The maximum BMY drawdown since its inception was -72.03%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for BMY and SCHD.
Loading graphics...
Drawdown Indicators
| BMY | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.03% | -33.37% | -38.66% |
Max Drawdown (1Y)Largest decline over 1 year | -25.79% | -12.74% | -13.05% |
Max Drawdown (5Y)Largest decline over 5 years | -47.67% | -16.85% | -30.82% |
Max Drawdown (10Y)Largest decline over 10 years | -47.67% | -33.37% | -14.30% |
Current DrawdownCurrent decline from peak | -12.07% | -3.43% | -8.64% |
Average DrawdownAverage peak-to-trough decline | -22.40% | -3.34% | -19.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.06% | 3.75% | +12.31% |
Volatility
BMY vs. SCHD - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 6.68% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.33%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BMY | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.68% | 2.33% | +4.35% |
Volatility (6M)Calculated over the trailing 6-month period | 19.39% | 7.96% | +11.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.61% | 15.69% | +12.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.68% | 14.40% | +9.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.08% | 16.70% | +8.38% |